Ureteroscope Market Report 2026

The ureteroscope market size has grown strongly in recent years. It will grow from $1.16 billion in 2025 to $1.23 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising prevalence of urolithiasis, expansion of urology specialty services, growing hospital investments in endoscopy equipment, increasing adoption of minimally invasive diagnostics, improved availability of trained urologists.

The ureteroscope market size is expected to see strong growth in the next few years. It will grow to $1.53 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing demand for disposable endoscopic devices, rising incidence of kidney disorders, expansion of outpatient urology procedures, technological advancements in digital imaging, growing focus on patient safety. Major trends in the forecast period include increasing adoption of single-use ureteroscopes, rising demand for high-definition imaging devices, growing preference for flexible ureteroscopes, expansion of minimally invasive urological procedures, enhanced focus on infection control.

The rising prevalence of renal diseases is expected to drive the growth of the ureteroscope market going forward. Renal diseases, or kidney diseases, encompass a wide range of conditions that impact kidney structure and function. The increasing prevalence of these diseases is influenced by factors such as genetic predisposition, lifestyle choices, environmental conditions, and underlying health issues. Ureteroscopes support the management of renal diseases by enabling diagnosis and treatment of kidney stones, tumors, strictures, and blockages through minimally invasive procedures, providing precise visualization and access to the urinary tract. For example, in June 2023, according to Kidney Research UK, a UK-based charity focused on research and advocacy for kidney health, approximately 7.19 million people in the UK were affected by chronic kidney disease in 2023, representing over 10% of the population, with projections reaching 7.61 million by 2033. Therefore, the increasing prevalence of renal diseases is propelling the growth of the ureteroscope market.

Leading companies in the ureteroscope market are developing innovative products such as single-use digital flexible ureteroscope systems to improve patient safety and reduce the risk of cross-contamination. Single-use digital flexible ureteroscope systems are disposable devices designed for a single procedure, featuring flexible shafts and advanced digital imaging technology. For instance, in February 2023, Boston Scientific, a US-based medical device manufacturer, received FDA approval for the LithoVue Elite System, a single-use digital flexible ureteroscope. This system offers enhanced image quality, intrarenal pressure monitoring, direct control over image and video capture, and seamless integration with existing operating room visualization towers and endoscopic monitors. It also includes an integrated sensor that allows urologists to monitor intrarenal pressure in real time during procedures, supporting informed, pressure-related clinical decisions.

In October 2023, Laborie Medical Technologies Inc., a US-based medical technology company, acquired Urotronic for approximately $600 million. This acquisition is part of Laborie’s strategy to strengthen its urology portfolio, particularly by leveraging Urotronic’s Optilume drug-coated balloon technology. Urotronic Inc., a US-based medical technology company, specializes in developing innovative solutions for urological applications.

Major companies operating in the ureteroscope market are Siemens Healthineers AG, Stryker Healthcare, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG, Richard Wolf GmbH, PENTAX Medical, Dornier MedTech, Cogentix Medical, Henke-Sass Wolf GmbH, Merit Medical Systems, Ambu A/S, Elmed Medical Systems Inc, OPCOM Medical Inc, Maxer Endoscopy GmbH, Rocamed SAM, NeoScope Inc, Teleflex Incorporated, Medtronic plc, Hoya Corporation.

North America was the largest region in the ureteroscope market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ureteroscope market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ureteroscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the ureteroscope market by increasing costs of imported optical fibers, imaging sensors, miniature cameras, and precision mechanical components used in digital and flexible ureteroscopes. Hospitals and ambulatory surgical centers in North America and Europe are most affected due to dependence on imported high-end devices, while Asia-Pacific faces pricing pressure on export-oriented manufacturing. These tariffs are increasing procurement costs and limiting device upgrades. However, they are also encouraging local assembly, regional sourcing of components, and development of cost-optimized ureteroscope designs.

The ureteroscope market research report is one of a series of new reports that provides ureteroscope market statistics, including ureteroscope industry global market size, regional shares, competitors with a ureteroscope market share, detailed ureteroscope market segments, market trends and opportunities, and any further data you may need to thrive in the ureteroscope industry. This ureteroscope market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A ureteroscope is a specialized medical device used mainly for diagnosing and treating conditions of the ureters, the tubes that transport urine from the kidneys to the bladder. It is a thin, flexible, or rigid endoscopic instrument equipped with a light source and camera, allowing urologists to visually examine the urinary tract. Ureteroscopes also facilitate therapeutic procedures such as lithotripsy and biopsy.

The main types of ureteroscopes include digital ureteroscopes, flexible ureteroscopes, rigid ureteroscopes, semi-rigid ureteroscopes, and fiberoptic ureteroscopes. Digital ureteroscopes are advanced tools used to visualize and treat the upper urinary tract, particularly for conditions like kidney stones. They are applied in various conditions, including urinary strictures, urolithiasis, kidney cancer, and diagnostics, and are utilized by end-users such as ambulatory surgical centers, specialty clinics, hospitals, urology clinics, diagnostic centers, endoscopic clinics, and others.

The ureteroscope market consists of the sale of optical system, insertion tube, distal tip, and working channel. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.